ACARE - Angioedema Centers of Reference and Excellence
Who We Are
What We Do
Our Approach
Our Mission
The GA2LEN | HAEi ACARE network is a joint initiative by GA²LEN, the Global Allergy and Asthma European Network, and HAEi, the global umbrella organization for the world’s hereditary angioedema patient groups.
The ACARE program is a joint initiative by GA²LEN and HAE International (HAEi) for developing and accrediting an interactive network of centers of reference and excellence in angioedema. Angioedema is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when recurrent.
The main aims of the GA²LEN | HAEi angioedema centers of reference and excellence (ACARE) program and network:
-
provide excellence in angioedema management
-
increase the knowledge of angioedema by research and education
-
promote the awareness of angioedema by advocacy activities.
-
broaden access to modern HAE medicines in countries where they are available
-
make concerted and systematic efforts to bring modern medicines to countries where there are none
Increase of the quality of life and information exchange worldwide
Latest News
Make A Difference 3rd Webinar – No Attacks, normal life, complete control – The aims of angioedema treatment
November 29th, 2021, 5:00 pm-6:00 pm CEST Register Here for free: Ärztekammer Berlin Accreditation received and CME Accreditation in review.
HAExpert Webinar registration now live „Ask the HAE experts: Treating special clinical cases“
The fourth in a series of interactive webinars, this virtual discussion-based event, led by a leading panel of international HAE experts, will explore a series of special clinical cases of patients with HAE (including pregnancy, adolescence, severe HAE and patients...
Urtic Hour live from France
On November 19th, Dr Isabelle Boccon-Gibod will speak at the Urtic Hour live from France. She is responsible for CREAK, the national reference center for angioedema at Grenoble University Hospital, which is dedicated to all patients with angioedema regardless of its...